CervoMed (STU:DP8) 3-Year EBITDA Growth Rate : 66.70% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is CervoMed 3-Year EBITDA Growth Rate?

CervoMed's EBITDA per Share for the three months ended in Mar. 2024 was €-0.39.

During the past 3 years, the average EBITDA Per Share Growth Rate was 66.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 65.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 58.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of CervoMed was 72.20% per year. The lowest was 9.20% per year. And the median was 60.25% per year.

Competitive Comparison of CervoMed's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, CervoMed's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CervoMed's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CervoMed's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where CervoMed's 3-Year EBITDA Growth Rate falls into.

CervoMed 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

CervoMed (STU:DP8) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

CervoMed 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of CervoMed's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

CervoMed (STU:DP8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CervoMed Inc (STU:DP8) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

CRVO:USA

Address

20 Park Plaza, Suite 424, Boston, MA, USA, 02216

Website

https://www.diffusionpharma.com

CervoMed Inc Formerly Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer. Geographically business activity of the firm functions through the region of the United States.

CervoMed (STU:DP8) Headlines

No Headlines